GlassScriptPhysician profile
Marsh R Mceachrane
NPI 1346214160
$5,372.09
in general payments reported to CMS, 2019-2025
40 companies · $585 in 2025
The $585 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $732 · 2020: $1,019 · 2021: $412 · 2022: $1,179 · 2023: $1,003 · 2024: $441 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,965 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,964.83 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $722.67 | 2019-2024 | |
| Organon LLC | $524.43 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $456.29 | 2019-2025 | |
| Gynesonics, INC. | $451.03 | 2020 | |
| Myovant Sciences INC. | $297.62 | 2021-2022 | |
| Astellas Pharma US INC | $241.11 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $197.56 | 2023-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $178.41 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $173.64 | 2019-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Cumberland Pharmaceuticals, INC. | $173.59 | 2019-2023 | Kristalose |
| Vertical Pharmaceuticals, LLC | $161.71 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $145.12 | 2022-2023 | Seglentis |
| Pfizer INC. | $137.83 | 2019-2024 | |
| Biotissue Holdings INC. | $133.39 | 2024-2025 | |
| Coopersurgical, INC. | $129.37 | 2019-2024 | Paragard T 380a, Paragard T 380a |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $124.94 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Aspira Women'S Health INC | $102.16 | 2020 | |
| Shield Therapeutics INC | $99.95 | 2023 | Accrufer |
| Mayne Pharma Commercial LLC | $87.66 | 2021-2023 | |
| Therapeuticsmd, INC. | $81.74 | 2019-2021 | |
| Avion Pharmaceuticals | $64.44 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $64.18 | 2019-2024 | Gardasil 9, Gardasil |
| Allergan, INC. | $63.22 | 2019-2020 | |
| Scynexis, INC. | $60.19 | 2022 | |
| Daiichi Sankyo INC. | $53.49 | 2019 | |
| Davol INC. | $49.58 | 2025 | Arista |
| Ethicon US, LLC | $44.81 | 2022-2024 | Vistaseal |
| Lupin INC. | $44.74 | 2019-2020 | |
| Viiv Healthcare Company | $40.76 | 2025 | Apretude |
| Mylan Pharmaceuticals INC. | $40.25 | 2019-2020 | |
| Biogen, INC. | $36.39 | 2025 | Zurzuvae |
| Merz North America, INC. | $36.01 | 2021-2023 | Xeomin |
| Agile Therapeutics, INC. | $32.07 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $27.99 | 2019 | |
| Mission Pharmacal Company | $22.61 | 2023 | Citranatal |
| Optumhealth Care Solutions, LLC | $18.61 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Medicem INC. | $17.86 | 2021 | |
| Duchesnay USA Incorporated | $15.46 | 2019 | |
| Amgen INC. | $11.61 | 2020 | |
| Channel Medsystems, INC. | $7.60 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marsh Mceachrane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.